AZT: Recurring, high-margin enzyme sales drive scalable growth across diversified biotech markets

A high-margin enzyme platform supports advanced therapies and diagnostics, generating recurring revenue and scaling margins. Diversified across four high-growth markets, the business leverages a largely fixed cost base for strong operating leverage and compounding earnings, with multiple growth lev…